Explore our resource hub below on topics such as streamlining cell therapy manufacturing workflows, gene editing innovations, scaling fill-finish, and more.
Featured Resource
Integrating Microbubbles into a CAR-T Workflow
Leveraging advancements in cell separation, this webinar shares innovations in CAR-T workflows using GMP-ready microbubbles.
Cryopreservation Methods for CAR-T Cells
Discover how different cryopreservation methods impact CAR-T cells when it comes to phenotype and function.
The Future of Fill and Finish
Delve into a new era of automated fill and finish with this whitepaper that addresses risks with contaminants and consistency in batches.
Making Gains in Non-viral Engineering of T Cells for Cell Manufacturing
In this study, we evaluated three leading electroporation platforms: Kytopen's Flowfect Tx™ and two blinded competitors to assess cell counts, flow cytometry, and potency.
Closed Automation Enables Quick Fill-Finish Poster
Find out how to maintain quality, consistency, and reduce risk during the critical step of fill-finish as well as scale T cell therapies.
Scaling CAR T Manufacturing with Automated Fill-Finish
Learn how to redefine large volume fill and finish with an automated solution that integrates multiple functionalities from formulation to filling drug product containers.
Achieving Consistency in Fill Finish for Cell Therapies
Learn how you can achieve consistency and reduce risks to ensure scale-out strategies for multiple bag requirements and post-thaw viability in a closed environment.
Comparing CAR T Cells Across Novel Cryopreservation Containers and Platforms
Learn more about current methods for cryopreservation processes and a novel container that is both more robust and adaptable for these potentially lifesaving cells.
Successfully Scale T Cell Products with the FINIA® Fill and Finish System
As the development of cell therapies continues to grow, demonstrating that this automated, scalable approach to fill finish can maintain product uniformity and quality is crucial.
Non-viral Engineering of T Cells
This 10-day study was performed using the same two donors with each platform. Cell viability, cell density, knockout efficiency, negative viable cells, and fold expansion were all measured.
Innovating Cell Therapy Manufacturing
Our work with Ori Biotech is part of a larger commitment to improve and scale advanced therapies to meet the growing patient demand for life-saving therapies.
Akron Bio
Explore how closed system automation is transforming cell therapy manufacturing by boosting efficiency, reducing risk, and accelerating delivery.